These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6954834)

  • 1. Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin.
    Rökaeus A
    Acta Physiol Scand Suppl; 1981; 501():1-62. PubMed ID: 6954834
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of neurotensin in disease.
    Rosell S; Rökaeus A; Theodorsson-Norheim E
    Scand J Gastroenterol Suppl; 1983; 82():59-67. PubMed ID: 6579628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect vascular actions of (Gln4)-neurotensin in canine adipose tissue.
    Rosell S; Rökaeus A; Chang D; Folkers K
    Acta Physiol Scand; 1978 Feb; 102(2):143-7. PubMed ID: 626094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and metabolic actions of neurotensin and (Gln4)-Neurotensin.
    Rosell S; Burcher E; Chang D; Folkers K
    Acta Physiol Scand; 1976 Dec; 98(4):484-91. PubMed ID: 998299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of bile and pancreatic juice for fat-induced release of neurotensin-like immunoreactivity (NTLI) from the small intestine of the rat.
    Rökaeus A; Al-Saffar A
    Acta Physiol Scand; 1983 Sep; 119(1):33-7. PubMed ID: 6650204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurotensin, a multi-action peptide hormone].
    St-Pierre S; Quirion R; Regoli D; Gervais A; Lavigne F; Poirier A; Jolicoeur F; Barbeau A; Rioux F
    Union Med Can; 1980 Oct; 109(10):1447-55. PubMed ID: 7466969
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of neurotensin in the uptake and distribution of fat.
    Rosell S
    Ann N Y Acad Sci; 1982; 400():183-97. PubMed ID: 6963111
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of neurotensin to the entero-pancreatic axis.
    Nustede R; Köhler H; Peiper M; Felmelden D; Fölsch UR; Schafmayer A
    Digestion; 1990; 46 Suppl 2():188-94. PubMed ID: 2262052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Caerulein].
    Saito T; Naito S
    Nihon Rinsho; 1970 Oct; 28(10):2438-43. PubMed ID: 5529045
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of neurotensin-immunoreactive cells in the small intestine of man and various mammals.
    Helmstaedter V; Taugner C; Feurle GE; Forssmann WG
    Histochemistry; 1977 Jul; 53(1):35-41. PubMed ID: 409699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of neurotensin-like immunoreactivity (NTLI) from rat intestine following administration of bombesin.
    Rökaeus A; McDonald T
    Acta Physiol Scand; 1980 Nov; 110(3):326. PubMed ID: 7211416
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of neurotensin-like immunoreactivity (NTLI) from the gut in anaesthetized dogs.
    Mashford ML; Nilsson G; Rökaeus A; Rosell S
    Acta Physiol Scand; 1978 Nov; 104(3):375-6. PubMed ID: 716989
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
    Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin. Studies on occurrence, release and inhibitory effect upon gastric acid secretion.
    Pedersen JH
    Dan Med Bull; 1995 Apr; 42(2):147-54. PubMed ID: 7664573
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities.
    Granier C; van Rietschoten J; Kitabgi P; Poustis C; Freychet P
    Eur J Biochem; 1982 May; 124(1):117-24. PubMed ID: 7084220
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology and biochemistry of neurotensin receptors.
    Kitabgi P; Checler F; Mazella J; Vincent JP
    Rev Clin Basic Pharm; 1985; 5(3-4):397-486. PubMed ID: 2881326
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological activity of neurotensin and its C-terminal partial sequences.
    Kataoka K; Taniguchi A; Shimizu H; Soda K; Okuno S; Yajima H; Kitagawa K
    Brain Res Bull; 1978; 3(5):555-7. PubMed ID: 122721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chimeras from regulatory peptides as a device for studying their action].
    Kharchenko EP; Sokolova TV; Kalikhevich VN; Shestak KI; Ardemasova ZA
    Dokl Akad Nauk SSSR; 1987; 297(5):1264-7. PubMed ID: 3446472
    [No Abstract]   [Full Text] [Related]  

  • 19. Ontogeny of brain neurotensin in the rat: a radioimmunoassay study.
    Bissette G; Richardson C; Kizer JS; Nemeroff CB
    J Neurochem; 1984 Jul; 43(1):283-7. PubMed ID: 6726254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.